Naslund Medical

Naslund Medical is a privately held Swedish medical technology company focused on products that support precision radiation oncology and related surgical guidance. Its flagship and apparently core commercial product is Gold Anchor, an implantable soft tissue fiducial marker designed to improve tumor localization, intrafraction motion management, CT/MRI fusion, and image-guided radiotherapy workflows. The company markets Gold Anchor globally and highlights use across multiple organs, including prostate, lung, breast, abdominal, gynecologic, and other tumor sites. Naslund Medical operates from Sweden and maintains subsidiaries in the United States, the United Kingdom, and France. The business appears to be a commercial-stage medtech company rather than a therapeutic drug developer, with revenue-generating products already on the market.